Universidad Complutense de Madrid
E-Prints Complutense

Oral re-vaccination of Eurasian wild boar with Mycobacterium bovis BCG yields a strong protective response against challenge with a field strain

Impacto

Downloads

Downloads per month over past year



Gortazar, Christian and Beltrán-Beck, Beatriz and Garrido, Joseba M and Aranaz Martín, Alicia and Sevilla, Iker A and Boadella, Mariana and Lyashchenko, Konstantin P and Galindo, Ruth C and Montoro, Vidal and Domínguez Rodríguez, Lucas and Juste, Ramón and De la Fuente, Jose (2014) Oral re-vaccination of Eurasian wild boar with Mycobacterium bovis BCG yields a strong protective response against challenge with a field strain. BMC veterinary research, 10 . p. 96. ISSN 1746-6148

[img]
Preview
PDF
Creative Commons Attribution.

531kB

Official URL: http://bmcvetres.biomedcentral.com/articles/10.1186/1746-6148-10-96



Abstract

BACKGROUND

Field vaccination trials with Mycobacterium bovis BCG, an attenuated mutant of M. bovis, are ongoing in Spain, where the Eurasian wild boar (Sus scrofa) is regarded as the main driver of animal tuberculosis (TB). The oral baiting strategy consists in deploying vaccine baits twice each summer, in order to gain access to a high proportion of wild boar piglets. The aim of this study was to assess the response of wild boar to re-vaccination with BCG and to subsequent challenge with an M. bovis field strain.

RESULTS

BCG re-vaccinated wild boar showed reductions of 75.8% in lesion score and 66.9% in culture score, as compared to unvaccinated controls. Only one of nine vaccinated wild boar had a culture-confirmed lung infection, as compared to seven of eight controls. Serum antibody levels were highly variable and did not differ significantly between BCG re-vaccinated wild boar and controls. Gamma IFN levels differed significantly between BCG re-vaccinated wild boar and controls. The mRNA levels for IL-1b, C3 and MUT were significantly higher in vaccinated wild boar when compared to controls after vaccination and decreased after mycobacterial challenge.

CONCLUSIONS

Oral re-vaccination of wild boar with BCG yields a strong protective response against challenge with a field strain. Moreover, re-vaccination of wild boar with BCG is not counterproductive. These findings are relevant given that re-vaccination is likely to happen under real (field) conditions.


Item Type:Article
Uncontrolled Keywords:Bacillus Camette Guerin, Sus scrofa, Tuberculosis, Vaccination and challenge, Wildlife disease control
Subjects:Medical sciences > Veterinary
ID Code:39637
Deposited On:20 Dec 2016 09:48
Last Modified:20 Dec 2016 09:48

Origin of downloads

Repository Staff Only: item control page